Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wieman

Showing results (261-270 of 394) with videos related to

Pageof 40
Sort By:
Psychiatric Services (Washington, D.C.)|October 11, 2005
Assessment of Medicaid managed behavioral health care for persons with serious mental illnessH Stephen Leff, Dow A Wieman, Bentson H McFarland, et al.
Pediatrics|July 9, 2025
Perinatal Substance Use and Factors Associated With Maternal and Neonatal Morbidity and MortalityMicah Piske, Youwei Yan, Fahmida Homayra, et al.
Ultramicroscopy|May 14, 2005
Active pixel sensor array as a detector for electron microscopyAnna-Clare Milazzo, Philippe Leblanc, Fred Duttweiler, et al.
Molecular and Cellular Biology|March 21, 2007
Glycogen synthase kinase 3alpha and 3beta mediate a glucose-sensitive antiapoptotic signaling pathway to stabilize Mcl-1Yuxing Zhao, Brian J Altman, Jonathan L Coloff, et al.
Movement Disorders Clinical Practice|September 29, 2023
Safety and Efficacy of Long-Term Deutetrabenazine Use in Children and Adolescents with Tics Associated with Tourette Syndrome: An Open-Label Extension StudyJoseph Jankovic, Barbara Coffey, Daniel O Claassen, et al.
JAMA Network Open|October 5, 2021
Safety and Efficacy of Flexible-Dose Deutetrabenazine in Children and Adolescents With Tourette Syndrome: A Randomized Clinical TrialJoseph Jankovic, Barbara Coffey, Daniel O Claassen, et al.
JAMA Network Open|October 18, 2021
Efficacy and Safety of Fixed-Dose Deutetrabenazine in Children and Adolescents for Tics Associated With Tourette Syndrome: A Randomized Clinical TrialBarbara Coffey, Joseph Jankovic, Daniel O Claassen, et al.
Allergy|October 7, 2024
Long-term safety and efficacy of garadacimab for preventing hereditary angioedema attacks: Phase 3 open-label extension studyAvner Reshef, Connie Hsu, Constance H Katelaris, et al.
Cancer|December 16, 2021
The Survivorship Sleep Program (SSP): A synchronous, virtual cognitive behavioral therapy for insomnia pilot program among cancer survivorsDaniel L Hall, Kimberly A Arditte Hall, Mark J Gorman, et al.
Sleep Medicine|February 5, 2023
Treatment-related changes in insomnia, anticipatory pleasure, and depression symptoms: A proof-of-concept study with cancer survivorsSarah T Wieman, Kimberly A Arditte Hall, Elyse R Park, et al.
Pageof 40

Showing results (261-270 of 394) with videos related to

Sort By:
Pageof 40
Psychiatric Services (Washington, D.C.)|October 11, 2005
Assessment of Medicaid managed behavioral health care for persons with serious mental illnessH Stephen Leff, Dow A Wieman, Bentson H McFarland, et al.
Pediatrics|July 9, 2025
Perinatal Substance Use and Factors Associated With Maternal and Neonatal Morbidity and MortalityMicah Piske, Youwei Yan, Fahmida Homayra, et al.
Ultramicroscopy|May 14, 2005
Active pixel sensor array as a detector for electron microscopyAnna-Clare Milazzo, Philippe Leblanc, Fred Duttweiler, et al.
Molecular and Cellular Biology|March 21, 2007
Glycogen synthase kinase 3alpha and 3beta mediate a glucose-sensitive antiapoptotic signaling pathway to stabilize Mcl-1Yuxing Zhao, Brian J Altman, Jonathan L Coloff, et al.
Movement Disorders Clinical Practice|September 29, 2023
Safety and Efficacy of Long-Term Deutetrabenazine Use in Children and Adolescents with Tics Associated with Tourette Syndrome: An Open-Label Extension StudyJoseph Jankovic, Barbara Coffey, Daniel O Claassen, et al.
JAMA Network Open|October 5, 2021
Safety and Efficacy of Flexible-Dose Deutetrabenazine in Children and Adolescents With Tourette Syndrome: A Randomized Clinical TrialJoseph Jankovic, Barbara Coffey, Daniel O Claassen, et al.
JAMA Network Open|October 18, 2021
Efficacy and Safety of Fixed-Dose Deutetrabenazine in Children and Adolescents for Tics Associated With Tourette Syndrome: A Randomized Clinical TrialBarbara Coffey, Joseph Jankovic, Daniel O Claassen, et al.
Allergy|October 7, 2024
Long-term safety and efficacy of garadacimab for preventing hereditary angioedema attacks: Phase 3 open-label extension studyAvner Reshef, Connie Hsu, Constance H Katelaris, et al.
Cancer|December 16, 2021
The Survivorship Sleep Program (SSP): A synchronous, virtual cognitive behavioral therapy for insomnia pilot program among cancer survivorsDaniel L Hall, Kimberly A Arditte Hall, Mark J Gorman, et al.
Sleep Medicine|February 5, 2023
Treatment-related changes in insomnia, anticipatory pleasure, and depression symptoms: A proof-of-concept study with cancer survivorsSarah T Wieman, Kimberly A Arditte Hall, Elyse R Park, et al.
Pageof 40